REIMAGINE IMMUNOTHERAPY
LIVE

Serial Number

99724695

Owner

Therakos Holdings USA, LLC

Attorney

Jeannine Rittenhouse

Filing Date

Mar 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

REIMAGINE IMMUNOTHERAPY Trademark

Serial Number: 99724695

REIMAGINE IMMUNOTHERAPY is a trademark filed by Therakos Holdings USA, LLC on March 25, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Therakos Holdings USA, LLC (2 trademarks)

4001 Kennett Pike, Suite 302
Wilmington, DE 19807

Entity Type: 16

Trademark Details

Filing Date

March 25, 2026

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

medical devices, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies

Medical services, namely, extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis

Pharmaceutical preparations for cellular therapy for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases and used in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 29, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 29, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2026 CNRT
ASSIGNED TO EXAMINER
Aug 5, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 25, 2026 MAFR
NEW APPLICATION ENTERED
Mar 25, 2026 NWAP